TRNT1
CCA tRNA nucleotidyltransferase 1, mitochondrial
Also known as: CCA1, CGI-47, MtCCA, TRNT1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96Q11
- Gene
- TRNT1
- Ensembl
- ENSG00000072756
- Chromosome
- 3
- Canonical length
- 434 aa
- Protein class
- Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a CCA-adding enzyme which belongs to the tRNA nucleotidyltransferase/poly(A) polymerase family. This essential enzyme functions by catalyzing the addition of the conserved nucleotide triplet CCA to the 3' terminus of tRNA molecules. Mutations in this gene result in sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Canonical amino-acid sequenceUniProt
434 residues, UniProt reviewed canonical sequence.
>Q96Q11|TRNT1
1 MLRCLYHWHR PVLNRRWSRL CLPKQYLFTM KLQSPEFQSL FTEGLKSLTE LFVKENHELR
61 IAGGAVRDLL NGVKPQDIDF ATTATPTQMK EMFQSAGIRM INNRGEKHGT ITARLHEENF
121 EITTLRIDVT TDGRHAEVEF TTDWQKDAER RDLTINSMFL GFDGTLFDYF NGYEDLKNKK
181 VRFVGHAKQR IQEDYLRILR YFRFYGRIVD KPGDHDPETL EAIAENAKGL AGISGERIWV
241 ELKKILVGNH VNHLIHLIYD LDVAPYIGLP ANASLEEFDK VSKNVDGFSP KPVTLLASLF
301 KVQDDVTKLD LRLKIAKEEK NLGLFIVKNR KDLIKATDSS DPLKPYQDFI IDSREPDATT
361 RVCELLKYQG EHCLLKEMQQ WSIPPFPVSG HDIRKVGISS GKEIGALLQQ LREQWKKSGY
421 QMEKDELLSY IKKTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRNT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- retina: 14 nTPM
- bone marrow: 13 nTPM
- urinary bladder: 12 nTPM
- kidney: 11 nTPM
- thyroid gland: 11 nTPM
- placenta: 10 nTPM
Single-cell type
- cardiomyocytes: 116 nCPM
- mast cells: 82 nCPM
- prostatic glandular cells: 78 nCPM
- pituicytes/fscs: 68 nCPM
- megakaryocyte-erythroid progenitors: 64 nCPM
- myonuclei: 61 nCPM
Immune cell
- basophil: 52 nTPM
- eosinophil: 38 nTPM
- memory B-cell: 28 nTPM
- naive CD4 T-cell: 24 nTPM
- NK-cell: 22 nTPM
- memory CD4 T-cell: 22 nTPM
Brain region
- white matter: 178 nTPM
- cerebellum: 174 nTPM
- cerebral cortex: 164 nTPM
- basal ganglia: 164 nTPM
- hypothalamus: 147 nTPM
- thalamus: 145 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TRNT1.
Disease | AllUniProt
Conditions TRNT1 is implicated in, by any mechanism.
- Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD) MIM:616084
- Retinitis pigmentosa and erythrocytic microcytosis (RPEM) MIM:616959
Disease | GeneticClinVar
81 pathogenic / likely-pathogenic of 649 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome
- Retinitis pigmentosa and erythrocytic microcytosis
- TRNT1-related disorder
- Retinal dystrophy
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.15
- DepMap mean gene effect
- -1.41
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mitochondrial tRNA 3'-end processing
- rescue of stalled ribosome
- tRNA 3'-end processing
- tRNA 3'-terminal CCA addition
- tRNA surveillance
Molecular functions
- ATP binding
- metal ion binding
- protein homodimerization activity
- tRNA binding
- 5'-3' RNA polymerase activity
- CCA tRNA nucleotidyltransferase activity
- CCACCA tRNA nucleotidyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Nucleotidyltransferase superfamily
- Poly A polymerase, head domain
- tRNA nucleotidyltransferase/poly(A) polymerase, RNA and SrmB- binding domain
- Bacterial CCA-adding enzyme type 3 subfamily
- Poly A polymerase head domain
- Probable RNA and SrmB- binding site of polymerase A
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRNT1 as an antibody target. Whether an autoantibody or antibody against TRNT1 could matter depends on whether native TRNT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRNT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRNT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...